The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $83.31

Today's change+0.37 +0.45%
Updated February 16 4:00 PM EST. Delayed by at least 15 minutes.
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $83.31

Today's change+0.37 +0.45%
Updated February 16 4:00 PM EST. Delayed by at least 15 minutes.

Medtronic PLC up (U.S.)$0.37

Medtronic PLC closed up Friday by (U.S.)$0.37 or 0.45% to (U.S.)$83.31. Over the last five days, shares have gained 4.82% and 3.17% year to date. Shares have underperformed the S&P 500 by 9.58% during the last year.

Key company metrics

  • Open(U.S.) $82.80
  • Previous close(U.S.) $82.94
  • High(U.S.) $83.76
  • Low(U.S.) $82.12
  • Bid / Ask-- / --
  • YTD % change+3.17%
  • Volume6,863,522
  • Average volume (10-day)6,098,528
  • Average volume (1-month)5,556,927
  • Average volume (3-month)5,498,778
  • 52-week range(U.S.) $76.52 to (U.S.) $89.72
  • Beta0.93
  • Trailing P/E22.82×
  • P/E 1 year forward17.46×
  • Forward PEG2.39×
  • Indicated annual dividend(U.S.) $1.84
  • Dividend yield2.21%
  • Trailing EPS(U.S.) $3.65
Updated February 16 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.29%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2018Q1/2018Q4/2017Q3/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 27, 201710/27/2017Jul 28, 201707/28/2017Apr 28, 201704/28/2017Jan 27, 201701/27/2017
Revenue7,0507,3907,9167,283
Total other revenue--------
Total revenue7,0507,3907,9167,283
Gross profit4,9305,0415,4805,015
Total cost of revenue2,1202,3492,4362,268
Total operating expense5,1496,0016,2856,136
Selling / general / administrative2,4382,4852,4792,388
Research & development555548553530
Depreciation / amortization460454496497
Interest expense (income), net operating--------
Unusual expense (income)-53599273407
Other operating expenses, total693548-21
Operating income1,9011,3891,6311,147
Interest income (expense), net non-operating-273-286-290-268
Gain (loss) on sale of assets--------
Other--------
Income before tax1,7281,1951,435967
Income after tax2,0131,0091,164820
Income tax, total-285186271147
Net income2,0171,0161,163821
Total adjustments to net income--------
Net income before extra. items2,0171,0161,163821
Minority interest47-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0171,0161,163821
Inc. avail. to common incl. extra. items2,0171,0161,163821
Diluted net income2,0171,0161,163821
Dilution adjustment--------
Diluted weighted average shares1,3661,3761,3821,383
Diluted EPS excluding extraordinary itemsvalue per share1.480.740.840.59
Dividends per sharevalue per share0.460.460.430.43
Diluted normalized EPSvalue per share1.220.801.000.84